Nicola Mikulcik Ohrner
Corporate Officer/Principal bei FORMYCON AG
Aktive Positionen von Nicola Mikulcik Ohrner
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
FORMYCON AG | Corporate Officer/Principal | 01.06.2022 | - |
bioeq GmbH
bioeq GmbH Pharmaceuticals: MajorHealth Technology bioeq GmbH develops biosimilar drugs. The company was founded in March 2014 and is headquartered in Holzkirchen, Germany. | Vorstandsvorsitzender | - | - |
Bioeq AG
Bioeq AG Pharmaceuticals: MajorHealth Technology Bioeq AG operates as a biopharmaceutical company, which licenses, develops and commercializes biological successor products. It offers FYB201, an advanced biosimilar program intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases. The company is headquartered in Zug, Switzerland. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Nicola Mikulcik Ohrner
Statistik
International
Deutschland | 3 |
Schweiz | 2 |
Operativ
Chief Executive Officer | 1 |
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
FORMYCON AG | Health Technology |
Private Unternehmen | 2 |
---|---|
Bioeq AG
Bioeq AG Pharmaceuticals: MajorHealth Technology Bioeq AG operates as a biopharmaceutical company, which licenses, develops and commercializes biological successor products. It offers FYB201, an advanced biosimilar program intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases. The company is headquartered in Zug, Switzerland. | Health Technology |
bioeq GmbH
bioeq GmbH Pharmaceuticals: MajorHealth Technology bioeq GmbH develops biosimilar drugs. The company was founded in March 2014 and is headquartered in Holzkirchen, Germany. | Health Technology |
- Börse
- Insiders
- Nicola Mikulcik Ohrner
- Erfahrung